Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 3 Component(s)

    This is the application for the online 2022 22nd Certificate in Travel Health™ Exam produced by the ISTM.

    The CTH® certificate recognizes professionals who have demonstrated expertise in the unique Body of Knowledge associated with travel medicine care and consultation.  

    ISTM will offer its 22nd Certificate of Knowledge™ in Travel Medicine live in Atlanta, Georgia USA on Saturday, 24 September 2022 at the Georgia Tech Global Learning Center.

    The deadline to apply to take the exam is 24 August 2022.


    Requirements:

    Please note that there are 3 REQUIRED components to this exam application. You must complete all 3 components in order for your application to be considered. If you fail to complete the required components you will not be allowed to enter the exam on exam day. 

    1. Applicant Questionnaire 

    2. Terms of Service (TOS) Acknowledgement

    3. Photo Identification Upload

    Please note that Non-ISTM Members must create ISTM profiles to apply to take the examination. Click here to create your profile then submit your application through the member application link.


    Special Accommodations:

    If you need special accommodations for the examination, please email learning@istm.org and submit your request within 30 days of the exam date. 


    Handouts Available:

    1. Candidate Bulletin

    2. CTH® Mark Use Policy

    3. Exam packet - you will receive your exam packet once all exam applications have been reviewed and accepted, no later than 24 August 2022.


    Future Exam Dates:

    Virtual/Online: March 2023, dates to be announced soon

    In-person: Sunday, 21 May 2023 at CISTM18 in Basel Switzerland


    Additional Information:

    1. You will receive at least two email from ISTM: (1) An initial confirmation of receipt of your application and payment and (2) Once your application has been reviewed and accepted, you will receive an email with your exam packet that includes complete exam instructions. You may receive additional emails if any updates need to be communicated so please make sure to read any emails from learning@istm.org and add us to your safe-senders list so the emails do not go to your spam folder. 

    2. Scoring: Please note that you will NOT receive a score immediately after taking the exam. Pass/Fail information will be emailed after the psychometricians have reviewed all of the completed exams. Please be patient as grading may take 8 to 10 weeks. In the interim, neither this system nor the ISTM Secretariat will have pass/fail information.

    • Register
      • Early bird pricing available!
      • Non-Member - $675
      • 5 Year Doctoral Level Member - $475
      • 5 Year Non-Doctoral Level Member - $350
      • Doctoral Level Members - $475
      • Associate Doctoral Level Members - $200
      • Retiree Doctoral Level Members - $475
      • Non-Doctoral Level Members - $350
      • Lifetime Retiree Doctoral Level Member - $475
      • Associate Non-Doctoral Level Members - $100
      • Retiree Non-Doctoral Level Members - $350
      • Lifetime Retiree Non-Doctoral Level Member - $350
      • Limited (Student/Trainee) Level Members - $350
      • Special Associate Member - $350
      • Staff/Administration - Free!
      • Hon. Lifetime Member - $475
      • Regular Price after 06/24/2022 11:59 PM
      • Non-Member - $775
      • 5 Year Doctoral Level Member - $575
      • 5 Year Non-Doctoral Level Member - $450
      • Doctoral Level Members - $575
      • Associate Doctoral Level Members - $200
      • Retiree Doctoral Level Members - $575
      • Non-Doctoral Level Members - $450
      • Lifetime Retiree Doctoral Level Member - $575
      • Associate Non-Doctoral Level Members - $100
      • Retiree Non-Doctoral Level Members - $450
      • Lifetime Retiree Non-Doctoral Level Member - $450
      • Limited (Student/Trainee) Level Members - $450
      • Special Associate Member - $450
      • Staff/Administration - Free!
      • Hon. Lifetime Member - $575
    • More Information
  • Contains 3 Component(s), Includes Credits Recorded On: 05/04/2022

    This webinar is brought to you by the ISTM Professional Education Committee (PEC)

    Title: Rabies Update: New Strategies for Travellers

    Date: Wednesday, 04 May 2022

    Time: 10.00 AM EDT UTC-04

    To check your time zone, go to the time and date website: Here

    Registration Fee: Complimentary to members; $70 USD for non-members

    You must register to attend the webinar. 


    Rabies, an almost invariably fatal disease, is estimated to cause at least 59,000 human deaths annually in over 150 countries, with 95% of cases occurring in Africa and Asia. Almost all of rabies cases are dog-mediated, with approximately half of cases occurring in children under 15.

    For travellers who sustain a bite from a potentially rabid animal, anxiety and trip disruptions can ensue. Albeit rare in travellers, rabies have catastrophic consequences.

    The cost of pre-exposure prophylaxis has been a major barrier to vaccine acceptance, so abbreviated schedules recently approved by the World Health Organisation (WHO) and the Advisory Committee on Immunization Practices (ACIP) may be a strategy to increase vaccine acceptance. 


    Webinar Speakers:

    PEC Chair: Sarah Kohl, MD
    PEC Co-Chair: Yen Bui, MD, DTMH
    Moderator: Prativa Pandey, MD
    Agam Rao, MD
    David Shlim, MD
    Leo Visser, MD, PhD


    Course Objectives: 

    By the end of this webinar, the attendee should be able to: 
    • Summarize the latest recommendations from WHO and ACIP
    • Discuss rabies prevention from a Travel Medicine perspective
    • Describe new products in development (vaccines, monoclonal antibodies)


    Who Should Attend:
    • Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists
    • Travel Health Practitioners – Doctors, Nurses, and Pharmacists
    • Occupational Health Practitioners
    • Public Health Practitioners
    • Family Medicine Practitioners
    • Any others who care for travelers and workers who might be exposed to rabies

    Sarah Kohl, MD

    Chair, Professional Education Committee

    UPMC Children's Hospital of Pittsburgh

    Sarah Kohl, MD is a Clinical Assistant Professor of Pediatrics at the University of Pittsburgh Medical School, USA. As a practicing general pediatrician, she applies epidemiologic principles to improve the health of her patients. She is Chair of the ISTM Professional Education Committee, a Fellow of the American Academy of Pediatrics and holds a Certificate in Travel Health. 

    Yen Bui, MD, DTMH

    Professional Education Committee, Co-Chair

    Department of Public Health, Quebec

    Dr. Bui has been working for the last 20 years as a Travel Health Consultant for the Department of Public Health of the Montérégie, Canada, where she provides advice and updates to Travel Health professionals. Her certifications include CTH® and CTropMed®. Dr Bui is one of the coauthors of the Quebec Immunization Protocol, as well as a member of the Quebec Advisory Committee on Travel Health, the Committee to Advise on Tropical Medicine and Travel, Canada, and the Working Group on Yellow Fever Vaccine. 

    Prativa Pandey, MD (Moderator)

    Medical Director, CIWEC Hospital and Travel Medicine center

    Founding President Nepal Travel Medicine Society

    Dr. Pandey was born in Nepal and obtained her medical degree in New Delhi, India. She did her residency training in Internal Medicine in Boston, USA and returned to Nepal after working for 10
    years in the Boston area.

    In Nepal, she joined the CIWEC Clinic and Travel Medicine Center, the oldest Travel Medicine Center in a developing country that had a rich tradition of research in travel associated illnesses under the leadership of Dr David R. Shlim. The CIWEC Clinic evolved into a hospital and Dr Pandey became the medical director of CIWEC hospital in 1998.

    She was elected a counselor of the International Society of Travel Medicine (ISTM) in 2003 and served as the President of the ISTM from 2005-2007. She is the founding President of Nepal Society of Travel Medicine. She opened the first Travel Medicine Center in Pokhara, Nepal in 2014. She served one season at the Himalayan Rescue Association (HRA) aid-post as a volunteer doctor at Pheriche near Everest base camp and currently serves on the medical advisory board of the HRA.

    CIWEC Hospital has participated in the global surveillance network called GeoSentinel since 1998 and Dr. Pandey has been the site director or co-site director for this project. Her publications include Traveler's Diarrhea - etiology and resistance, Altitude Illness, Pulmonary Embolism at high altitude, a novel treatment for Frostbite, in addition to other Travel Medicine related topics. 

    Agam Rao, MD

    Physician

    U.S. Centers for Disease Control and Prevention’s Division of High Consequence Pathogens and Pathology

    Dr. Agam Rao is a physician with the U.S. Centers for Disease Control and Prevention’s Division of High Consequence Pathogens and Pathology. She is board certified in infectious diseases and is a Captain in the Commissioned Corps of the U.S. Public Health Service. Dr. Rao’s areas of public health expertise include developing national guidelines (e.g., recommendations of the U.S. Advisory Committee on Immunization Practices); characterizing clinical features of high consequence pathogens (i.e., rabies, poxviruses, and botulism); and investigating, both domestical and international outbreaks of infections.

    David Shlim, MD

    Medical Director, Jackson Hole Travel and Tropical Medicine; Medical Editor, Health Information for International Travel (The Yellow Book)

    Chairman, The Medicine and Compassion Project, Jackson Hole, Wyoming

    Dr. Shlim is the author of over fifty-five original research papers and has written over twenty chapters in textbooks on travel medicine.  He is an editor of the CDC’s Health Information for International Travel, and a co-author of the chapter on rabies in that book.  He is a past president of the International Society of Travel Medicine, and the current chairman of The Medicine and Compassion Projectâ.

    He pioneered travel medicine research on travelers’ diarrhea, typhoid fever, hepatitis, altitude illness, trekking deaths, and rabies. He also helped discover the diarrhea causing protozoal pathogen Cyclospora.

    Dr. Shlim is the co-author, with Chokyi Nyima Rinpoche, of Medicine and Compassion, a book that offers advice from a Tibetan Buddhist lama on methods of training in compassion for health care professionals.  His new memoir, A Gentle Rain of Compassion, will be published in September 2022.


    Prof Leo G. Visser, MD, PhD

    Infectious Diseases and LUMC travel clinic, Department Head

    Leiden University Medical Center

    Professor Leo Visser studied medicine at the University of Leuven in Belgium. He specialized in Infectious Diseases at the Leiden University Medical Center, where he obtained his PhD (1997). He was appointed as Professor in Infectious Diseases and Travel Medicine in 2014.

    For many years, Professor Visser is involved in clinical care, research, teaching and training in internal medicine and infectious diseases, with the emphasis on vaccinology, vaccine-preventable and tropical infectious diseases, travel medicine and global health.

    Professor Visser holds a position as Head of the Department of Infectious Diseases and LUMC travel clinic at the LUMC. The travel clinic is member of the Leiden Vaccine Group and is a centre of expertise for travel medicine and vaccination research in The Netherlands.

    Professor Visser holds several positions at national and international committees and scientific organizations. Currently, Professor Visser is member of the European Expert Committee for Travel Medicine. In the past he was, amongst others, member of the steering committee of the European Network on the Surveillance of Imported Infectious Diseases (www.tropnet.eu), chair of the National Coordination Centre for Travellers' Health Advice (LCR), and President of the International Society of Travel Medicine.

    His current research activities involve the safety and immunogenicity of alternative vaccination routes and vaccine responses in the more vulnerable individual with chronic diseases, advanced age, or immunosuppressed in particular those following solid organ transplantation or receiving immunobiologicals.

    • Register
      • Non-Member - $70
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 6 Component(s), Includes Credits Recorded On: 03/23/2022

    This webinar is brought to you by the ISTM Professional Education Committee (PEC) in collaboration with the ISTM Pediatric Interest Group

    Title:   COVID-19 Vaccines and Kids: Lessons Learned and Remaining Challenges 

    Date:   23 March 2022

    Time:  16.00 EDT UTC-04 (4:00 PM EDT UTC-04)

    To check your time zone, go to the time and date website: Here


    Webinar Support

    ISTM would like to extend a special thank you to Sanofi Pasteur for their generous support with an unrestricted educational grant!

    image

    Webinar Program Planning Information

    This webinar is brought to you by the ISTM Professional Education Committee (PEC) in collaboration with the ISTM Pediatric Interest Group.

    Chair: Sarah Kohl, United States

    Co-Chair: Yen-Giang Bui, Canada

    Immediate Past President ISTM: Lin Chen, United States

    PEDS Chair: Sheila Mackell, United States

    Moderator: John C. Christenson, United States

    Speakers:

    Elizabeth Barnett, United States

    Margie Danchin, Australia

    Leah D. Kern, United States


    Summary:

    Even though children and adolescents may be less physically affected by COVID-19, their lives have suffered enormous disruptions through school closures and socially distancing measures. The Omicron variant with its higher transmissibility has caused an important increase in the total number of cases of COVID-19 in younger age groups. The full impact of late complications such as MIS-C, long COVID, plus the effects of social isolation, lack of stimulation on kids’ development will linger on long after this pandemic is over. Effective and safe vaccines against COVID-19 have been available since last fall, but vaccine hesitancy in parents and questions around rare side effects such as myocarditis have hindered vaccinal uptake.

    Our experts will share with you the latest epidemiological data on the burden of this pandemic in children and adolescents, and review vaccines’ effectiveness and safety in these age groups. They will also review strategies to overcome vaccine hesitancy and optimize vaccination coverage.


    Course Objectives:

    By the end of this webinar, the attendee should be able to:

    • Review the latest epidemiological data on COVID-19 in children and adolescents, including MIS-C
    • Recognize the psychosocial burden of the pandemic on children and adolescents 
    • Discuss the effectiveness and safety of COVID-19 vaccines in children and adolescents
    • Explore the reasons for vaccine hesitancy in parents and use effective communication strategies to overcome them


    Who Should Attend:

    • Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists
    • Travel Health Practitioners – Doctors, Nurses, and Pharmacists
    • Public Health Practitioners
    • Family Medicine Practitioners
    • Paediatricians
    • Any others who care for travelers and children

    The webinar is complimentary to members and non-members, but you still must register to attend. The webinar Zoom link will be sent to you in your registration confirmation email.

    Elizabeth Barnett, MD

    Professor of Pediatrics

    Boston University School of Medicine, USA

    Elizabeth Barnett is a pediatrician with a specialty in infectious diseases working in an urban hospital with a large international population.  Her career focus has been in general pediatric infectious diseases, travel and topical medicine, immigrant medicine, vaccines and vaccine safety, and antimicrobial therapy and resistance.  With colleagues in the adult infectious diseases group, she founded the Travel Clinic at Boston Medical Center in the early 1990s and the Refugee Health Assessment Program a few years later.  Her research interests have included travel medicine – through the Boston Area Travel Medicine Network (BATMN), a collaboration of 5 travel clinics in the Greater Boston Area – immigrant medicine, and vaccines, including participation in clinical trials of Japanese Encephalitis vaccine in children and oral cholera vaccine.  Dr. Barnett has been Site Director for the Boston GeoSentinel site since the 1990s, contributing over 6000 records.  Current academic and administrative activities include being the Pediatric Infectious Diseases Fellowship Program Director, a member of the BUSM Promotions Committee, and a member of the Leadership Group of GeoSentinel.  Dr. Barnett has also been active in ISTM for over 20 years, including participation in the Migrant Interest Group, and Director/Co-Director of the ISTM Review Course.

    John C. Christenson, MD, FAAP, FIDSA, FPIDS (Moderator)

    Professor of Clinical Pediatrics at the Indiana University School of Medicine

    Director of the Pediatric Travel Medicine Clinic at Riley Hospital for Children, USA

    Dr. John C. Christenson is a Professor of Clinical Pediatrics at the Indiana University School of Medicine and Director of the Pediatric Travel Medicine Clinic at Riley Hospital for Children. He completed his medical studies and pediatric residency at the University of Puerto Rico in San Juan, Puerto Rico, followed by a fellowship in pediatric infectious diseases at the University of Oklahoma Health Sciences Center. Dr. Christenson is board-certified in pediatric infectious diseases, and has a Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health from the American Society of Tropical Medicine and Hygiene, and a Certificate of Knowledge in Travel Health from the International Society of Travel Medicine. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. Dr. Christenson has for many years been involved in international educational and health projects in Guatemala, Central America. His clinical interests are medical education, infection prevention, travel and geographic medicine, clinical infectious diseases, histoplasmosis, and immunizations. 

    Margie Danchin, MBBS, PhD, FRACP

    A/Prof and Clinician Scientist Fellow

    Murdoch Children's Research Institute and The University of Melbourne in Melbourne, Australia

    A/Prof Margie is consultant paediatrician within the Department of Paediatrics, University of Melbourne and Murdoch Childrens Research Institute (MCRI). She is Group Leader, Vaccine acceptance, Uptake and Policy, at MCRI, and is an immunisation expert with over ten years of experience in vaccine research and clinical work, both in Australia and in resource poor settings. She has expertise in vaccine clinical trials, vaccine safety, program evaluation, health system strengthening and implementation research in low resource settings, social science and vaccine policy. Her research program is focused on improving vaccine confidence, demand and uptake of licensed vaccines in different settings and populations.

    This is achieved by developing, trialing and translating effective, multi-component interventions in pregnancy and early childhood, in at risk populations and in low resource settings. She is also developing a new tool to enable diagnosis of the causes of under-vaccination in different populations to ensure cost-effective, targeted interventions to improve vaccine uptake in children under 5 years. She is at the forefront of understanding vaccine confidence nationally and internationally and has strong collaborations with leaders in the field.

    She is the current chair of the Collaboration on Social Science in Immunisation (COSSI) Group, an initiative of the National Centre for Immunisation Research and Surveillance (NCIRS), a member of Sabin's Vaccine and Acceptance Research Network (VARN) steering group and is engaged as a WHO consultant to address the rise in measles cases and vaccine confidence issues in the Philippines.

    Leah D. Kern, MD, MPH

    Associate Clinical Professor of Pediatrics

    Division of Academic General Pediatrics, University of California, San Diego, USA

    As an Associate Clinical Professor of Academic General Pediatrics, I focus my career on providing direct clinical care to patients and on educating medical students and residents with a concentration on pediatric HIV care, pediatric travel medicine and general pediatrics. 

    From 2006-2008, I worked for the Baylor International Pediatric AIDS Initiative in Burkina Faso and provided direct medical care to several hundred HIV-exposed and HIV-infected children.  From 2009 until 2014, I served as advisor to the prevention of mother-to-child transmission (PMTCT) and pediatric HIV components of UCSD's Program for PEPFAR Support to the Uniformed Services of Ethiopia (USE). Since 2015, I have worked as a pediatrician for the UCSD Mother, Child, and Adolescent HIV Program. I provide direct patient care for HIV-exposed infants and for HIV infected children and adolescents. I also focus on educating UCSD medical students and residents about the care of HIV-exposed infants and HIV-infected children.

    At UCSD Academic General Pediatrics, I provide general pediatrics care and am the Director of the Pediatric Travel Clinic. I provide pre- and post-travel consults for children traveling internationally. Currently, I am the principal investigator of a research project to examine the pre-travel health preparation of children and young adults by general pediatricians compared with the travel medicine clinic.

    My other research interests focus on the implementation of the American Academy of Pediatrics’ universal screening recommendations the in General Pediatrics clinic. Over the past several years, I have conducted research related to universal cholesterol screening in children and post-partum depression screening in infants’ mothers. Recently, I completed research to evaluate the long-term impact of universal lipid screening and the physician management of those with dyslipidemia among children aged 9-11 years old. Currently, I am the principal investigator on a project to examine the long-term impact and follow-up of the mother-infant dyad of mothers screening positive for post-partum depression.

    I plan to continue to focus my research on improving the quality of care for children in the general pediatrics clinic, the pediatrics travel clinic and the HIV clinic.

    • Register
      • Non-Member - Free!
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 6 Product(s)

    The annual ISTM TMRUC will be offered online 11 - 12 February 2022 due to continuing COVID-19 travel concerns. This will be a hybrid virtual event of live and pre-recorded presentations.

    COURSE DATES & FORMAT:

    The annual ISTM TMRUC will be offered online 11 - 12 February 2022. This will be a hybrid virtual event of live and pre-recorded presentations. Participants will have ample opportunity to interact with the faculty through interactive sessions and informal discussions. The course will be available on-demand after the live event. 


    COURSE DESCRIPTION

    The Travel Medicine Review and Update Course is designed to review the ISTM Body of Knowledge for the Practice of Travel Medicine and to highlight recent developments in Travel Medicine. The curriculum will cover topics relevant to physicians, nurses, and other health care professionals who provide medical care and advice to travellers, expatriates, and migrants.

    Sessions offered will include principles of immune response, risk assessment, and a travel vaccine overview. The expert faculty will present topics including adventure travel, bites and envenomation, cases, food and water exposures, ill returning travellers, risk assessment, malaria, yellow fever, special travellers, vaccines, and vectors. The care of special groups such as pregnant women, pediatric travellers, immigrants, VFR travellers, diabetics, and immunocompromised hosts will also be discussed. Recent developments and advances in travellers' diarrhea, immunizations, malaria medications, and navigating COVID in travel will be highlighted.


    COURSE CHAIR

    Elizabeth A. Talbot, MD

    Travel Medicine Review and Update Course, Chair

    Deputy State Epidemiologist, NH DHHS

    Professor of Medicine, Infectious Diseases and International Health, Dartmouth, New Hampshire, USA


    COURSE PLANNING COMMITTEE

    Elizabeth A. Talbot, United States

    Lin Chen, United States

    Yen-Giang Bui, Canada

    Sarah Kohl, United States


    COURSE SPEAKERS

    Aisha Khatib, Canada

    Camilla Rothe, Germany

    David Hamer, United States

    David Freedman, United States

    Elizabeth Barnett, United States

    Gerard Flaherty, Ireland

    Henry Wu, United States

    Lin Chen, United States

    Mary-Louise Scully, United States

    Michael Jones, United Kingdom

    Sarah Kohl, United States

    Sheila Mackell, United States


    INTERNATIONAL PANEL ON YELLOW FEVER

    Jane Chiodini, United Kingdom

    Jenny Visser, New Zealand

    Leo Visser, Netherlands

    Mary-Louise Scully, United States

    Salim Parker, South Africa

    Moderator: Yen-Giang Bui, Canada


    INTERNATIONAL PANEL ON MALARIA

    Dipti Patel, United Kingdom

    Mike Starr, Australia

    Patricia Schlagenhauf, Switzerland

    Steve Schofield, Canada

    Moderator: Francesco Castelli, Italy


    COURSE MODERATORS

    Camilla Rothe, Germany

    Christina Coyle, United States

    David Shlim, United States

    Francesco Castelli, Italy

    Gerard Flaherty, Ireland

    Yen-Giang Bui, Canada


    CREDIT HOURS

    image


    Accreditation Statement:

    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society of Travel Medicine (ISTM).  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physicians (ACCME) Credit Designation:

    Amedco LLC designates this live activity / enduring material for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Nurses (ANCC) Credit Designation:

    Amedco LLC designates this live activity / enduring material for a maximum of 16.25 ANCC contact hours.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation:

    Amedco LLC designates this live activity / enduring material for a maximum of 9.75 knowledge-based CPE contact hours.

    * NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. 

    • Register
      • Non-Member - $450
      • 5 Year Doctoral Level Member - $350
      • 5 Year Non-Doctoral Level Member - $350
      • Doctoral Level Members - $350
      • Associate Doctoral Level Members - $350
      • Retiree Doctoral Level Members - $350
      • Non-Doctoral Level Members - $350
      • Lifetime Retiree Doctoral Level Member - $350
      • Associate Non-Doctoral Level Members - $350
      • Retiree Non-Doctoral Level Members - $350
      • Lifetime Retiree Non-Doctoral Level Member - $350
      • Limited (Student/Trainee) Level Members - $350
      • Special Associate Member - $350
      • Staff/Administration - Free!
      • Hon. Lifetime Member - $350
    • More Information
  • Contains 3 Component(s), Includes Credits

    Immunosuppressed Patient

    Challenging Cases is designed by the ISTM to bridge the gap and support the CTH® qualified practitioner in maintaining their personal CPD in travel medicine and also accruing credits towards their CTH® re-accreditation every 10 years.

    The cases are selected from clinical feedback and each practitioner has a chance to answer them in their own time and then compare their responses to the experts opinions which will be published the following month.

    Each completed case is awarded a one-hour credit towards re-accreditation.

    Instructions:

    Download the case. 

    Write your response and retain for your own records in order to compare to the expert opinion.

    The expert opinion will be posted 1 month from the date of the case.

    You will receive 1 CPD credit hour per case. 

    Derek Paul Evans

    Challenging Cases Project Leadership

    Director and Owner, Evans Healthcare Consultancy Ltd

    Clinical Pharmacist Practitioner and Educator

    An experienced pharmacist and independent prescriber who brings clinical, training and management experience from national companies and private practice. My experience is based on providing education and learning from the experience of a clinical pharmacist practitioner practising in NHS and private medicine. My goal is to develop new healthcare providers through specifically designed education courses, reviews and feedback and clinical support in my areas of specialism. By combining this with my business experience I provide extended support to qualified healthcare professionals so they can expand their clinical practice and increase their levels of commercialism.

     CAREER & EDUCATION HISTORY

    Evans Healthcare Consultancy Ltd. - Director and owner. Date 2015- present.

    A specialist consultancy in the supply of travel health, travel medicine and related services. I supply regular prescribing and clinical cover to private travel health clinics; consultancy advice and course writing for training companies providing pharmacist education training; professional article writing and presentations, and practice based research.

    Job Title – Pharmacy Area Manager and Travel Health Specialist for Morrison Supermarkets PLC. Date: 2003-2014.

    TRAVEL HEALTH SPECIALIST PRESCRIBER

    Working within one of the largest supermarket groups in the UK provided the opportunity to supply travel health services through the pharmacy division and also through to corporate travellers. As much of the food lines are sourced internationally the buyers for each line have a responsibility to visit producers overseas to ensure the quality of product and the conditions for the cultivation, including use of overseas workers. The requests for vaccinations and the supply of antimalarials, bite avoidance measures etc. was co-ordinated by myself through company pharmacies for supply to the traveller.

    My clinical qualifications and prescriber role provided me with the opportunity to sit on the company panel for the internal accreditation and design the use of Patient Group Directives (PGDs) for the supply of travel vaccinations, travel anti-malarials for pharmacists. Through the course of writing the company internal training, assessment and quality audit documents, I was able to deliver the inaugural Travel Health Conference for 85 pharmacy clinics.

    Prof Leo G. Visser, MD, PhD

    Infectious Diseases and LUMC travel clinic, Department Head

    Leiden University Medical Center

    Professor Leo Visser studied medicine at the University of Leuven in Belgium. He specialized in Infectious Diseases at the Leiden University Medical Center, where he obtained his PhD (1997). He was appointed as Professor in Infectious Diseases and Travel Medicine in 2014.

    For many years, Professor Visser is involved in clinical care, research, teaching and training in internal medicine and infectious diseases, with the emphasis on vaccinology, vaccine-preventable and tropical infectious diseases, travel medicine and global health.

    Professor Visser holds a position as Head of the Department of Infectious Diseases and LUMC travel clinic at the LUMC. The travel clinic is member of the Leiden Vaccine Group and is a centre of expertise for travel medicine and vaccination research in The Netherlands.

    Professor Visser holds several positions at national and international committees and scientific organizations. Currently, Professor Visser is member of the European Expert Committee for Travel Medicine. In the past he was, amongst others, member of the steering committee of the European Network on the Surveillance of Imported Infectious Diseases (www.tropnet.eu), chair of the National Coordination Centre for Travellers' Health Advice (LCR), and President of the International Society of Travel Medicine.

    His current research activities involve the safety and immunogenicity of alternative vaccination routes and vaccine responses in the more vulnerable individual with chronic diseases, advanced age, or immunosuppressed in particular those following solid organ transplantation or receiving immunobiologicals.

    • Register
      • Non-Member - Free!
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 3 Component(s), Includes Credits Recorded On: 01/19/2022

    This webinar is brought to you by the ISTM Professional Education Committee (PEC)

    Summary:

    Dengue has been recognized as the most frequent arboviral infection in tropical and sub-tropical regions of the world, with an estimated 390 million people infected each year, and 100 million developing illness. The disease is spreading to new areas including Europe. Autochthonous cases are now observed on an almost annual basis in many European countries, with the risk of local outbreaks where the mosquito vector exists. Among ill travellers returning from some regions, eg South-East Asia, the Caribbean etc. dengue is the most diagnosed cause of fever. With global warming and increased urbanization, dengue will continue to pose a threat to endemic populations as well as travellers.

    This webinar is Series 2 of 2 of Dengue and COVID-19 focused webinars. You can find Series 1 on the webinar page of the LMS.


    Attendee Takeaways:

    1. Risk factors for contracting dengue in travellers
    2. Clinical manifestations of dengue in travellers vs those in endemic populations
    3. Enhanced understanding of cost-of-illness related to dengue in travellers
    4. The importance of pretravel consultation in preventing dengue in traveller

    By the end of this webinar, the attendee should be able to:

    1. Discuss the epidemiology of dengue in travelers.
    2. Discuss the latest data on cost-of-illness related to dengue in travellers.
    3. Examine the effectiveness of commonly advised personal protection measures to prevent dengue in travellers

    Who Should Attend:

    1. Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists

    2. Travel Health Practitioners – Doctors, Nurses, and Pharmacists

    3. Public Health Practitioners

    4. Family Medicine Practitioners

    5. Any others who care for travelers and migrants


    Note:

    You must register to attend the webinar. The Zoom link will be provided in your registration email or you may attend by accessing the webinar on your LEARNING @ ISTM dashboard.

    • Register
      • Non-Member - Free!
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 2 Component(s), Includes Credits

    Long Term Travellers and Mosquito Borne Diseases

    Challenging Cases is designed by the ISTM to bridge the gap and support the CTH® qualified practitioner in maintaining their personal CPD in travel medicine and also accruing credits towards their CTH® re-accreditation every 10 years.

    The cases are selected from clinical feedback and each practitioner has a chance to answer them in their own time and then compare their responses to the experts opinions which will be published the following month.

    Each completed case is awarded a one-hour credit towards re-accreditation.

    Instructions:

    Download the case. 

    Write your response and retain for your own records in order to compare to the expert opinion.

    The expert opinion will be posted 1 month from the date of the case.

    You will receive 1 CPD credit hour per case. 

    Derek Paul Evans

    Challenging Cases Project Leadership

    Director and Owner, Evans Healthcare Consultancy Ltd

    Clinical Pharmacist Practitioner and Educator

    An experienced pharmacist and independent prescriber who brings clinical, training and management experience from national companies and private practice. My experience is based on providing education and learning from the experience of a clinical pharmacist practitioner practising in NHS and private medicine. My goal is to develop new healthcare providers through specifically designed education courses, reviews and feedback and clinical support in my areas of specialism. By combining this with my business experience I provide extended support to qualified healthcare professionals so they can expand their clinical practice and increase their levels of commercialism.

     CAREER & EDUCATION HISTORY

    Evans Healthcare Consultancy Ltd. - Director and owner. Date 2015- present.

    A specialist consultancy in the supply of travel health, travel medicine and related services. I supply regular prescribing and clinical cover to private travel health clinics; consultancy advice and course writing for training companies providing pharmacist education training; professional article writing and presentations, and practice based research.

    Job Title – Pharmacy Area Manager and Travel Health Specialist for Morrison Supermarkets PLC. Date: 2003-2014.

    TRAVEL HEALTH SPECIALIST PRESCRIBER

    Working within one of the largest supermarket groups in the UK provided the opportunity to supply travel health services through the pharmacy division and also through to corporate travellers. As much of the food lines are sourced internationally the buyers for each line have a responsibility to visit producers overseas to ensure the quality of product and the conditions for the cultivation, including use of overseas workers. The requests for vaccinations and the supply of antimalarials, bite avoidance measures etc. was co-ordinated by myself through company pharmacies for supply to the traveller.

    My clinical qualifications and prescriber role provided me with the opportunity to sit on the company panel for the internal accreditation and design the use of Patient Group Directives (PGDs) for the supply of travel vaccinations, travel anti-malarials for pharmacists. Through the course of writing the company internal training, assessment and quality audit documents, I was able to deliver the inaugural Travel Health Conference for 85 pharmacy clinics.

    • Register
      • Non-Member - Free!
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 3 Component(s), Includes Credits Recorded On: 12/01/2021

    This webinar is brought to you by the ISTM Professional Education Committee (PEC)

    With vaccination campaigns against COVID-19 progressing in most countries, consensus is emerging about SARS-CoV-2 evolving towards endemicity. Shifting our paradigm from crisis management to risk management has brought new challenges for all sectors of society. Ensuring travellers’ and workers’ safety while allowing normal life to resume is of paramount concern.

     Attendee Takeaways:

    Our experts will review the latest data on air travel safety, and share lessons learned on how to mitigate the risk of COVID-19 in air travel and in workplaces.

    * Discuss the data on the risk of COVID-19 and air travel

    * Summarize the protocols put in place to ensure air travel safety

    * Discuss the lessons learned to ensure workers’ safety, particularly in the mining industry

    Who Should Attend:

    * Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists

    * Travel Health Practitioners – Doctors, Nurses, and Pharmacists

    * Public Health Practitioners

    * Family Medicine Practitioners

    * Occupational Health Practitioners

    * Any others who care for travellers

    Note: This is a live Zoom webinar. To attend, you may access the webinar Zoom link on your dashboard after registration.

    Therese Maarschalk, MBChB (Moderator)

    Chief Medical Officer Travel Doctor Corporate; Chief Medical Officer De Beers Consolidated Mines

    Occupational Medical Practitioner Anglo American Corporate Clinic

    Therese Maarschalk is a travel health practitioner at Travel Doctor Corporate doing pre- and post-travel consultations and looking after some 3000 expatriates worldwide. After working in Malawi and the UK she did diplomas in obstetrics, anaesthetics, tropical medicine and occupational health while in general practice.


    Therese did the first certificate in Travel Medicine at WITS in 2000 and delivered papers and posters at the ISTM conferences in New York, Edinburgh, Melbourne, Shanghai and AECTM.
    She is the CMO for De Beers Consolidated Mining and the volunteer Palliative Care doctor at a HIV/AIDS Hospice for homeless people in Hillbrow.

    Aisha Khatib, MD, CCFP(EM), CTravMed, DTM&H, CTropMed

    Assistant Professor, Dept of Family and Community Medicine, University of Toronto

    Clinical Director Travel Medicine, Travel Doctor and Medical Consultant, Medcan

    Dr. Aisha Khatib (MD, CCFP(EM), CTravMed, DTM&H, CTropMed) is an Assistant Professor with the Department of Family & Community Medicine at the University of Toronto.  She trained in both family and emergency medicine from the University of Toronto and McGill University, and recently completed an Infectious Diseases fellowship in Clinical Tropical Medicine at the University of Toronto.  She holds specialization in Travel and Tropical Medicine, having completed a certification in Travel Medicine from the University of Otago in New Zealand, and a Diploma in Tropical Medicine and Hygiene from the Gorgas Course in Peru.  She worked as a Travel, Rugby, and Occupational Health Doctor in New Zealand with Worldwise Traveller’s Health for several years before moving back to Canada.  She is currently the Clinical Director of Travel Medicine at Medcan, and also consults on their Medical Advisory Services Team.  She holds many positions including President-Elect of the Alberta Association of Travel Health Professionals, Councilor on the American Society of Tropical Medicine & Hygiene Clinical Group, and Chair of the ISTM Responsible Travel Interest Group.  She is also Co-Chair of the ASTMH Update Course in Clinical Tropical Medicine and Travelers' Health. Her recent research interests focus on the safety of air travel during the COVID-19 pandemic. 

    Vanessa Govender, MBBCh, MPH, and DOH

    Director, Masakhane Strategic Health Consulting, Johannesburg, South Africa

    Lecturer, Occupational Health Division, School of Public Health, University of Witwatersrand, Johannesburg, South Africa

    Dr Vanessa Govender’s occupational medicine and public health career spans more than 25 years in the mining industry in South Africa. She has held various leadership positions at global companies such as Gold Fields and Aveng Group. She has also served as Chair of the Board of the South African Business Coalition on Health and Aids (SABCOHA), Chair of the Mining Industry Occupational Safety and Health (MOSH) dust committee, the Certification Committee at the Medical Bureau for Occupational Diseases (MBOD) and as President of the Mine Medical Professionals Association (MMPA). Her career has navigated all aspects of health and wellness in the mining industry and she has experienced, first-hand, the toils and triumphs of how the industry has transformed, and still is transforming.

    Vanessa completed her undergraduate medical degree (MBBCh, 1993) and postgraduate studies (Diploma in Occupational Health (DOH, 1999) and Masters in Public Health, Policy and Management (MPH, 2007)  at the University of the Witwatersrand in Johannesburg, South Africa. In addition, she has completed numerous international executive business education courses at Harvard TH Chan School of Public Health and the Wits and London Schools of Business. She is a researcher, speaker and lecturer, and has published scientific papers in peer- reviewed journals and contributed to two book chapters: most recently on mental health in the workplace, highlighting the role of corporate companies in providing supportive workplaces.

    In 2019, acknowledging her contribution and clinical acumen in the field of occupational medicine, Vanessa was appointed as a Specialist: Occupational Medicine by the Health Professions Council of South Africa.

    In the last six years, through her company, Masakhane Strategic Health Consulting (Pty) Ltd, Vanessa has consulted widely to diverse clients (including the United Nations Office on Drugs and Crime, and the Minerals Council South Africa), bringing-cutting edge knowledge to inform policy, strategy, leadership behaviours, and clinical standards for the prevention, early diagnosis, and compensation of occupational diseases. She is passionate about driving health strategy beyond legislative compliance, and ending smoking AND occupational lung diseases - the latter bringing untold suffering to mineworkers, their families and the public health system.

     Vanessa currently holds the position of consultant to Anglo American's global COVID-19 response, applying her philosophy of ‘science, art and heart’ to health risk communication and  strategic occupational health projects. She is a lecturer / academic coordinator for the Post Graduate Diploma in Occupational Health at the Wits School of Public Health, and an associate member of the Colleges of Public Health Medicine of South Africa. She is a member of the Medical Advisory Panel to the Tshiamiso Trust, which was established in response to the R5 bn Silicosis Class Action settlement.

     Vanessa has also contributed extensively to debates on compensation legislation and strongly believes that through her work we can uphold the dignity of workers.

     She believes that education is a lifelong journey of joy and that medicine should be practised with “science, art and heart”, meaning that, while scientific evidence informs our decisions, we have to constantly apply ourselves in the real world by joining all the dots (art)  and placing the patient at the centre within the full context of the psychosocial-political situation (heart).

    • Register
      • Non-Member - Free!
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 3 Component(s), Includes Credits Recorded On: 10/20/2021

    This webinar is brought to you by the ISTM Professional Education Committee (PEC)

    The COVID-19 pandemic has created special challenges in countries that are highly endemic for dengue. In this Zoom webinar, our experts will highlight these challenges and bring you the latest, most up to date information. Current clinical findings, effectiveness of control measures including vector control strategies, as well as interactions between SARS-CoV-2 and dengue viruses will be examined. Our webinar will focus on Thailand and Brazil, two very popular travel destinations that are highly endemic for dengue, as these countries currently fight the spread of COVID-19. 

    This webinar is Series 1 of 2 of Dengue and COVID-19 focused webinars. You can find Series 2 on the webinar page of the LMS.

    Attendee Takeaways:
    • What are the most common risks for dengue?
    • How to advise a traveller during pre-travel screening.
    • Learn typical clinical manifestations of the different forms of dengue and COVID-19, especially with variants.
    • Enhanced understanding of how travellers can reduce their risk for dengue and Covid-19 and their complications.
    • Recognize the current situation in countries that are highly endemic for Dengue.

    * Please note that this is a Zoom webinar. To join the webinar, login to your Learning @ ISTM account and go to your dashboard. Click the webinar link in the contents tab. Google Chrome is the recommended browser for Zoom webinars. 

    Karin Leder, MD, MPH, PhD (Moderator)

    Physician and Professor

    Monash University, Royal Melbourne Hospital

    Professor Karin Leder is an infectious diseases physician, Head of the Infectious Diseases Epidemiology Unit in the School of Public Health and Preventive Medicine at Monash University, and Head of Travel Medicine and Immigrant Health Services at the Victorian Infectious Disease Service, Royal Melbourne Hospital. She is a Fellow of the Royal Australasian College of Physicians, has a Masters of Public Health (Harvard University) and a PhD (Monash University, received Vice-Chancellor’s commendation for doctoral thesis excellence). She holds a NHMRC Senior Research Fellowship (2019 – 2023). 

    Prof Leder is involved in diverse areas of clinical and public health infectious disease research. Major foci of work include risks of infections from exposure to contaminated environments and unsafe water, factors associated with spread of infections across international borders, global surveillance of health risks associated with travel, tropical medicine, vaccination and prevention of infections, research design, and public health assessment. 

    Prof Leder has published over 270 research publications and book chapters. She is the Travel Medicine Section Editor and an invited co-author on 28 chapters for UpToDate, a widely used clinician's tool. She has been an invited expert the World Health Organisation’s strategies for International Travel and Health, an advisor to the Australian Academy of Health and Medical Sciences, past-president of the Asia Pacific Society of Travel Medicine, recent Board Member for the International Society of Travel Medicine, Associate Editor for the Journal of Travel Medicine and Infectious Diseases, a Regional Advisor for the Journal of Travel Medicine, and an advisor to the Australian Spleen Registry. She serves on the Executive for the School of Public Health and Preventive Medicine at Monash University and is a leader for Monash’s Centre to Impact Antimicrobial Resistance (AMR). She has served on the NHMRC Research Translation Faculty for New and Emerging Health Threats Steering Group, the NHMRC Joint Steering Committee for National Guidelines on Water Recycling, the NHMRC Water Quality Advisory Committee and the NHMRC Training Awards Committee. She has been a Scientific Chair at multiple international travel medicine conferences. In 2018 she won the Frank Fenner award from the Australasian Society of Infectious Diseases. 

    Prof Leder is a member of the executive team for the Monash-led five-year RISE project (https://www.rise-program.org/) that will investigate the impact of improved environmental health on human health outcomes in informal communities. The project will provide sustainable water and sewage management to 24 slums in Fiji and Indonesia, and will investigate impacts on the physical and microbiological health of the environment and inhabitants. She is also CIA on an IDEAS grant (2020-2024) assessing the relative importance of pathogen acquisition by a range of exposure pathways. She has also led work examining the health effects of rainwater consumption, and her group is a leading resource for industry and government agencies for issues related to water and health. 

    Prof Leder has a Leadership role in and is the Australian GeoSentinel site director for the largest global sentinel surveillance system for imported infections. She has led or contributed to multiple collaborative internationally renowned research projects using these data, with outputs used to update international WHO and CDC guidelines for travel medicine. She has regularly contributed as an expert consultant for the WHO in International Travel and Health, and was an invited expert for WHO’s priority pathogens list. 

    Prof Leder has extensive experience with student supervision, mentoring and teaching, and runs courses on Infectious Disease Epidemiology for Monash’s Masters of Public Health. She has also played a key role in the Australian COVID response, including as a leading contributor to Australian National COVID-19 Clinical Evidence Taskforce, as an author of the Roadmap to Recovery report submitted to Government, via international collaborations to monitor spread of SARS-CoV-2 across international borders, and via a secondment to the Victorian Department of Health and Human Services to assist with their outbreak response.

    Karin is a founding member of the Monash Centre to Impact AMR and is developing our AMR strategy within the Asia-Pacific region.

     

    Annelies Wilder-Smith, MD, PhD, DTM&H, MIH, FAMS, FACTM

    Professor of Infectious Diseases

    London School of Hygiene and Tropical Medicine

    Professor Annelies Wilder-Smith is Full Professor with Tenure for Infectious Diseases Research at Lee Kong Chian School of Medicine (LKCMedicine) which she joined in May 2013. Since July 2017, she only maintains a part-time position at LKC, as she is working as Consultant for Arboviral Diseases at the World Health Organization (WHO) in Geneva, Switzerland. At the Initiative for Vaccine Research (IVR) at WHO, her tasks are to deal with the WHO response to the safety issues of the first licensed dengue vaccine, coordinating research on the use of fractional dose of the yellow fever vaccine, and developing a Zika vaccine roadmap.

    Aluisio Segurado, MD, PhD

    President, University of Sao Paulo, Brazil

    Professor of Infectious Diseases, Universidade de São Paulo Faculdade de Medicina: Sao Paulo, São Paulo, Brazil

    Dr. Aluisio Segurado received his MD and PhD degrees from the University of São Paulo, where he is currently Full Professor of Infectious Diseases at the Faculty of Medicine. In the same institution he also acts as President of Hospital das Clinicas Central Institute Board and President of the International Relations Committee. Dr. Segurado has been involved in clinical studies related to infectious diseases and tropical medicine throughout his academic career and is currently conducting a cohort study to investigate the natural history and viral kinetics of ZIKV in Brazil as part of the ZikAlliance Research Consortium under the sponsorship of the European Commission. His research focuses on human retroviral infections (HIV/AIDS, HTLV) with particular interest on vulnerability to viral acquisition, disease progression and response to interventions.

    Pornthep Chanthavanich, MD

    Professor of Tropical Medicine

    Mahidol University, Thailand

    Pornthep Chanthavanich is an Associate Professor at the Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University. He graduated in medicine from Siriraj Medical School, Mahidol University. He holds postgraduate qualifications in DTM&H (Bangkok), MSc.MCH (London), DTCH (Liverpool), Dip. Thai Board of Pediatrics Infectious Diseases, Dip. Thai Board of Preventive Medicine (Travel Medicine). He was previously Head of the Department of Tropical Pediatrics, Deputy Director of Hospital for Tropical Diseases (Bangkok), and Deputy Dean of Faculty of Tropical Medicine, Mahidol University. He is now the President of Thai Society of Travel Medicine, Immediate Past President of Asia Pacific Travel Health Society, Secretary-General of Asian Society for Pediatric Infectious Diseases, Treasurer of International Society of Tropical Pediatrics. His research interests have been in travel medicine, vaccines, tropical medicine, and infectious diseases.

    • Register
      • Non-Member - $70
      • 5 Year Doctoral Level Member - Free!
      • 5 Year Non-Doctoral Level Member - Free!
      • Doctoral Level Members - Free!
      • Associate Doctoral Level Members - Free!
      • Retiree Doctoral Level Members - Free!
      • Non-Doctoral Level Members - Free!
      • Lifetime Retiree Doctoral Level Member - Free!
      • Associate Non-Doctoral Level Members - Free!
      • Retiree Non-Doctoral Level Members - Free!
      • Lifetime Retiree Non-Doctoral Level Member - Free!
      • Limited (Student/Trainee) Level Members - Free!
      • Special Associate Member - Free!
      • Staff/Administration - Free!
      • Hon. Lifetime Member - Free!
    • More Information
  • Contains 60 Product(s)

    This is the 17th meeting of the International Society of Travel Medicine.

    This is the 17th meeting of the International Society of Travel Medicine. It was the first virtual conference of the ISTM so for the first time, all sessions were recorded and are available to you. The theme of the conference is the “The Changing Face of Travel Medicine: Anticipating its Global Impact.” 


    CME Credits:

    For full information, visit: https://www.istm.org/cistm17-cme

    How to Get Your Certificate:

    1. Go to http://istm.cmecertificateonline.com
    2. Click on the Activity Title that corresponds to your profession: 
        a. 2021 - The 17th Conference of the International Society of Travel Medicine - PHARMACISTS ONLY - ENDURING ONLY 
        b. 2021 - The 17th Conference of the International Society of Travel Medicine - DOCTORS AND NURSES ONLY - ENDURING ONLY
    3. Evaluate the meeting
    4. Questions? Email Certificate@AmedcoEmail.co

    • Register
      • Non-Member - $595
      • 5 Year Doctoral Level Member - $495
      • 5 Year Non-Doctoral Level Member - $395
      • Doctoral Level Members - $495
      • Associate Doctoral Level Members - $200
      • Retiree Doctoral Level Members - $495
      • Non-Doctoral Level Members - $395
      • Lifetime Retiree Doctoral Level Member - $495
      • Associate Non-Doctoral Level Members - $200
      • Retiree Non-Doctoral Level Members - $395
      • Lifetime Retiree Non-Doctoral Level Member - $395
      • Limited (Student/Trainee) Level Members - $150
      • Special Associate Member - $200
      • Staff/Administration - Free!
      • Hon. Lifetime Member - $495
    • More Information